{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T05:51:49Z","timestamp":1762062709314,"version":"build-2065373602"},"reference-count":108,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The activation of phospholipase C (PLC) is thought to have a key role in the cardiomyocyte response to several different hypertrophic agents such as norepinephrine, angiotensin II and endothelin-1. PLC activity results in the generation of diacylglycerol and inositol trisphosphate, which are downstream signal transducers for the expression of fetal genes, increased protein synthesis, and subsequent cardiomyocyte growth. In this article, we describe the signal transduction elements that regulate PLC gene expression. The discussion is focused on the norepinephrine- \u03b11-adrenoceptor signaling pathway and downstream signaling processes that mediate an upregulation of PLC isozyme gene expression. Evidence is also indicated to demonstrate that PLC activities self-regulate the expression of PLC isozymes with the suggestion that PLC activities may be part of a coordinated signaling process for the perpetuation of cardiac hypertrophy. Accordingly, from the information provided, it is plausible that specific PLC isozymes could be targeted for the mitigation of cardiac hypertrophy.<\/jats:p>","DOI":"10.3390\/cells11162488","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T05:43:57Z","timestamp":1660196637000},"page":"2488","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8307-2760","authenticated-orcid":false,"given":"Paramjit S.","family":"Tappia","sequence":"first","affiliation":[{"name":"Asper Clinical Research Institute, St. Boniface Hospital, Winnipeg, MB R2H 2A6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naranjan S.","family":"Dhalla","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences & Department of Physiology & Pathophysiology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/14728222.9.5.963","article-title":"Targeting calcineurin and associated pathways in cardiac hypertrophy and failure","volume":"9","author":"Fiedler","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.phrs.2010.07.003","article-title":"Multifarious molecular signaling cascades of cardiac hypertrophy: Can the muddy waters be cleared?","volume":"62","author":"Balakumar","year":"2010","journal-title":"Pharmacol. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jcp.21094","article-title":"Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses","volume":"212","author":"Clerk","year":"2007","journal-title":"J. Cell Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/CBB:47:1:21","article-title":"Differential signaling and hypertrophic responses in cyclically stretched vs endothelin-1 stimulated neonatal rat cardiomyocytes","volume":"47","author":"Dekkers","year":"2007","journal-title":"Cell Biochem. Biophys."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00018-016-2373-0","article-title":"How cardiomyocytes sense pathophysiological stresses for cardiac remodeling","volume":"74","author":"Haque","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1006\/jmcc.1997.0523","article-title":"Signaling pathways in cardiac myocyte hypertrophy","volume":"29","author":"Hefti","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1091\/mbc.E16-01-0038","article-title":"Biology of the cardiac myocyte in heart disease","volume":"27","author":"Peter","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"110972","DOI":"10.1016\/j.mce.2020.110972","article-title":"The endocrinological component and signaling pathways associated to cardiac hypertrophy","volume":"518","author":"Takano","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14728222.2022.2031974","article-title":"Emerging therapeutic targets for cardiac hypertrophy","volume":"26","author":"Winkle","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.yjmcc.2007.07.046","article-title":"Overt expression of AP-1 reduces alpha myosin heavy chain expression and contributes to heart failure from chronic volume overload","volume":"43","author":"Freire","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/01.CIR.0000160367.99928.87","article-title":"AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program","volume":"111","author":"Jeong","year":"2005","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1074\/jbc.274.13.9006","article-title":"Transcriptional activation of the glucose transporter GLUT1 in ventricular cardiac myocytes by hypertrophic agonists","volume":"274","author":"Montessuit","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1073\/pnas.0712316105","article-title":"Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: Role of calcineurin\/NFAT as Ca2+ signal integrators","volume":"105","author":"Colella","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jmb.2007.10.006","article-title":"Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB","volume":"375","author":"Gupta","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Robinson, E.L., Drawnel, F.M., Mehdi, S., Archer, C.R., Liu, W., Okkenhaug, H., Alkass, K., Aronsen, J.M., Nagaraju, C.K., and Sjaastad, I. (2022). MSK-mediated phosphorylation of histone H3 Ser28 couples MAPK signalling with early gene induction and cardiac hypertrophy. Cells, 11.","DOI":"10.3390\/cells11040604"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.CIR.84.3.1256","article-title":"Proximal regulatory domains of rat atrial natriuretic factor gene","volume":"84","author":"Rosenzweig","year":"1991","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"H796","DOI":"10.1152\/ajpheart.2000.278.3.H796","article-title":"Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice","volume":"278","author":"Saadane","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/bj3470275","article-title":"Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro","volume":"347","author":"Aoki","year":"2000","journal-title":"Biochem. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02190548","article-title":"Adrenergic agents, but not triiodo-L-thyronine induce c-fos and c-myc expression in the rat heart","volume":"86","author":"Hannan","year":"1991","journal-title":"Basic Res. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1006\/jmcc.1993.1127","article-title":"Expression of c-fos and related genes in the rat heart in response to norepinephrine","volume":"25","author":"Hannan","year":"1993","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11480","DOI":"10.1073\/pnas.88.24.11480","article-title":"Localization and regulation of c-fos and c-jun protooncogene induction by systolic wall stress in normal and hypertrophied rat hearts","volume":"88","author":"Schunkert","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1073\/pnas.88.12.5453","article-title":"CD3 stimulation causes phosphorylation of phospholipase C-\u03b3 1 on serine and tyrosine residues in a human T-cell line","volume":"88","author":"Park","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.2000.3255","article-title":"Differential regulation of phospholipase C-\u03b2 isozymes in cardiomyocyte hypertrophy","volume":"275","author":"Schnabel","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"101065","DOI":"10.1016\/j.plipres.2020.101065","article-title":"Phospholipase C families: Common themes and versatility in physiology and pathology","volume":"80","author":"Katan","year":"2020","journal-title":"Prog. Lipid. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-94-007-2888-2_10","article-title":"Phospholipase C","volume":"740","author":"Vines","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_27","first-page":"88","article-title":"Angiotensin II induced upregulation of G \u03b1q\/11, phospholipase C \u03b23 and extracellular signal-regulated kinase 1\/2 via angiotensin II type 1 receptor","volume":"117","author":"Bai","year":"2004","journal-title":"Chin. Med. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1097\/00005344-199526003-00031","article-title":"Endothelin-1-induced phospholipase C-beta and D and protein kinase C isoenzyme signaling leading to hypertrophy in rat cardiomyocytes","volume":"26","author":"Lamers","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_29","first-page":"372","article-title":"Signal transduction of mechanical stress in myocytes and fibroblasts derived from neonatal rat ventricles","volume":"9","author":"Ruwhof","year":"2001","journal-title":"Neth. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1054\/ceca.2000.0158","article-title":"Mechanical stress stimulates phospholipase C activity and intracellular calcium ion levels in neonatal rat cardiomyocytes","volume":"29","author":"Ruwhof","year":"2001","journal-title":"Cell Calcium"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.yjmcc.2009.08.020","article-title":"Selective activation of the \u201cb\u201d splice variant of phospholipase C\u03b21 in chronically dilated human and mouse atria","volume":"47","author":"Woodcock","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1111\/jcmm.14330","article-title":"The role of post-translational modifications in cardiac hypertrophy","volume":"23","author":"Yan","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"828549","DOI":"10.3389\/fphar.2022.828549","article-title":"Transcription factors involved in the development and prognosis of cardiac remodeling","volume":"13","author":"Hong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.pharmtox.46.120604.141223","article-title":"Regulation of phospholipase C isozymes by ras superfamily GTPases","volume":"46","author":"Harden","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14497","DOI":"10.1016\/S0021-9258(18)68247-X","article-title":"Monoclonal antibodies to three phospholipase C isozymes from bovine brain","volume":"263","author":"Suh","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-94-007-3012-0_3","article-title":"The phospholipase C isozymes and their regulation","volume":"58","author":"Gresset","year":"2012","journal-title":"Subcell. Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.plipres.2010.06.001","article-title":"Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance","volume":"49","author":"Fukami","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"816369","DOI":"10.3389\/fcvm.2022.816369","article-title":"Role and mechanism of PKC-\u03b4 for cardiovascular disease: Current status and perspective","volume":"9","author":"Miao","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10741-017-9634-3","article-title":"Protein kinase C and cardiac dysfunction: A review","volume":"22","author":"Singh","year":"2017","journal-title":"Heart Fail. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cardiores.2005.05.015","article-title":"The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes","volume":"68","author":"Barac","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yjmcc.2008.05.014","article-title":"Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes","volume":"45","author":"Zima","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0022-2828(08)80043-0","article-title":"Subunit expression of signal transducing G proteins in cardiac tissue: Implications for phospholipase C-\u03b2 regulation","volume":"27","author":"Hansen","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1006\/jmcc.1996.0235","article-title":"Identification and characterization of G protein-regulated phospholipase C in human myocardium","volume":"28","author":"Schnabel","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.cellsig.2012.01.009","article-title":"Role of phospholipase C\u03b5 in physiological phosphoinositide signaling networks","volume":"24","author":"Smrcka","year":"2012","journal-title":"Cell Signal."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0092-8674(88)90548-X","article-title":"Cloning and sequence of multiple forms of phospholipase C","volume":"54","author":"Suh","year":"1988","journal-title":"Cell."},{"key":"ref_46","first-page":"H40","article-title":"Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: Partial correction by imidapril","volume":"277","author":"Tappia","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_47","first-page":"I-241","article-title":"Specific expression of phospholipase C-\u03b41 and \u03b31 by adult cardiac ventricular Myocytes","volume":"88","author":"Wolf","year":"1993","journal-title":"Circulation"},{"key":"ref_48","first-page":"315","article-title":"Regulation and physiological functions of mammalian phospholipase C","volume":"161","author":"Nakamura","year":"2017","journal-title":"J. Biochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-009-0296-x","article-title":"Phospholipase C\u03b24 isozyme is expressed in human, rat, and murine heart left ventricles and in HL-1 cardiomyocytes","volume":"337","author":"Otaegui","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.biochem.70.1.281","article-title":"Regulation of phosphoinositide-specific phospholipase C","volume":"70","author":"Rhee","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"25335","DOI":"10.1016\/S0021-9258(18)47252-3","article-title":"Regulation of phospholipase C-\u03b24 by ribonucleotides and the alpha subunit of Gq","volume":"269","author":"Lee","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1074\/jbc.RA118.002354","article-title":"G protein \u03b2\u03b3 subunits directly interact with and activate phospholipase C\u03f5","volume":"293","author":"Madukwe","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2880001","article-title":"Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors","volume":"288","author":"Cockcroft","year":"1992","journal-title":"Biochem. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0009-3084(99)00013-4","article-title":"Regulation of phospholipase C isozymes: Activation of phospholipase C-\u03b3 in the absence of tyrosine-phosphorylation","volume":"98","author":"Sekiya","year":"1999","journal-title":"Chem. Phys. Lipids."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1139\/o99-059","article-title":"Fibroblast growth factor-2 stimulates phospholipase C\u03b2 in adult cardiomyocytes","volume":"77","author":"Tappia","year":"1999","journal-title":"Biochem. Cell. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1021\/bi9702288","article-title":"Phosphoinositide binding specificity among phospholipase C isozymes as determined by photo-cross-linking to novel substrate and product analogs","volume":"36","author":"Tall","year":"1997","journal-title":"Biochemistry"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1074\/jbc.273.1.417","article-title":"Replacements of single basic amino acids in the pleckstrin homology domain of phospholipase C-\u03b41 alter the ligand binding, phospholipase activity, and interaction with the plasma membrane","volume":"273","author":"Yagisawa","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/REP-07-0332","article-title":"Increased potency of \u03b11-adrenergic receptors to induce inositol phosphates production correlates with the up-regulation of \u03b11d\/Gh \u03b1\/phospholipase C \u03b41 signaling pathway in term rat myometrium","volume":"135","author":"Dupuis","year":"2008","journal-title":"Reproduction"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/en.2009-0722","article-title":"Nonmuscle myosin IIA (myosin heavy polypeptide 9): A novel class of signal transducer mediating the activation of G\u03b1h\/phospholipase C-\u03b41 pathway","volume":"151","author":"Lin","year":"2010","journal-title":"Endocrinology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.RES.72.5.966","article-title":"Phosphatidylinositol metabolism in hypertrophic rat heart","volume":"72","author":"Kawaguchi","year":"1993","journal-title":"Circ. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1253\/jcj.56.142","article-title":"Phosphatidylinositol and inositolphosphatide metabolism in hypertrophied rat heart","volume":"56","author":"Shoki","year":"1992","journal-title":"Jpn. Circ. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1582-4934.2006.tb00412.x","article-title":"Losartan attenuates phospholipase C isozyme gene expression in hypertrophied hearts due to volume overload","volume":"10","author":"Dent","year":"2006","journal-title":"J. Cell. Mol. Med."},{"key":"ref_63","first-page":"H719","article-title":"Phospholipase C gene expression, protein content and activities in cardiac hypertrophy and heart failure due to volume overload","volume":"282","author":"Dent","year":"2004","journal-title":"Am. J. Physiol."},{"key":"ref_64","first-page":"573","article-title":"Aortic constriction induces hypertension and cardiac hypertrophy via (pro)renin receptor activation and the PLC-\u03b23 signaling pathway","volume":"19","author":"Wu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_65","first-page":"H2298","article-title":"PKC translocation without changes in G\u03b1q and PLC-\u03b2 protein abundance in cardiac hypertrophy and failure","volume":"277","author":"Jalili","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/01.RES.0000196578.15385.bb","article-title":"Phospholipase C \u03b5 modulates \u03b2-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy","volume":"97","author":"Wang","year":"2005","journal-title":"Circ. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0002-8703(89)90267-6","article-title":"Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophy","volume":"118","author":"Ganguly","year":"1989","journal-title":"Am. Heart J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.1073\/pnas.95.17.10140","article-title":"Enhanced G\u03b1q signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure","volume":"95","author":"Adams","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1073\/pnas.94.15.8121","article-title":"Transgenic G\u03b1q overexpression induces cardiac contractile failure in mice","volume":"94","author":"Sakata","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1161\/01.CIR.97.15.1488","article-title":"Decompensation of pressure-overload hypertrophy in G\u03b1q-overexpressing mice","volume":"97","author":"Sakata","year":"1998","journal-title":"Circulation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1172\/JCI8497","article-title":"Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1","volume":"105","author":"Sussman","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"13893","DOI":"10.1073\/pnas.95.23.13893","article-title":"Transient cardiac expression of constitutively active G\u03b1q leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways","volume":"95","author":"Mende","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1006\/jmcc.2001.1411","article-title":"Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein \u03b1q: Lack of correlation between phospholipase C activation and the phenotype","volume":"33","author":"Mende","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"23012","DOI":"10.1074\/jbc.M111.231993","article-title":"Phospholipase C \u03b5 scaffolds to muscle-specific A kinase anchoring protein (mAKAP\u03b2) and integrates multiple hypertrophic stimuli in cardiac myocytes","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"37341","DOI":"10.1074\/jbc.M106572200","article-title":"Evidence for selective coupling of \u03b11-adrenergic receptors to phospholipase C-\u03b21 in rat neonatal cardiomyocytes","volume":"276","author":"Arthur","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1096\/fj.07-102558","article-title":"The extreme C-terminal region of phospholipase C\u03b21 determines subcellular localization and function; the \u201cb\u201d splice variant mediates alpha1-adrenergic receptor responses in cardiomyocytes","volume":"22","author":"Grubb","year":"2008","journal-title":"FASEB J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1096\/fj.09-133983","article-title":"Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase C\u03b21b","volume":"23","author":"Filtz","year":"2009","journal-title":"FASEB J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11010-009-0061-1","article-title":"Regulation of c-Fos and c-Jun gene expression by phospholipase C activity in adult cardiomyocytes","volume":"327","author":"Singal","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/j.1582-4934.2009.00812.x","article-title":"Reciprocal regulation of transcription factors and PLC isozyme gene expression in adult cardiomyocytes","volume":"14","author":"Singal","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.yjmcc.2006.03.004","article-title":"Norepinephrine-induced changes in gene expression of phospholipase C in cardiomyocytes","volume":"41","author":"Singal","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-2828(86)80459-X","article-title":"\u03b1-adrenergic mechanisms in the pathophysiology of left ventricular heart failure-An analysis of their role in systolic and diastolic dysfunction","volume":"18","author":"Giles","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/00005344-198706106-00020","article-title":"Regression of cardiac hypertrophy: Experimental and clinical results","volume":"10","author":"Motz","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1536\/ihj.25.461","article-title":"Effect of prolonged prazosin treatment on hemodynamic and biochemical changes in the dog heart due to chronic pressure overload","volume":"25","author":"Prasad","year":"1984","journal-title":"Jpn. Heart J."},{"key":"ref_84","first-page":"S39","article-title":"The influence of sympathetic nervous activity on regression of cardiac hypertrophy","volume":"3","author":"Strauer","year":"1985","journal-title":"J. Hypertens. Suppl."},{"key":"ref_85","first-page":"171","article-title":"Progression and regression of heart hypertrophy in arterial hypertension: Pathophysiology and clinical aspects","volume":"74","author":"Strauer","year":"1995","journal-title":"Z. Kardiol."},{"key":"ref_86","first-page":"1","article-title":"Reversal of cardiac remodeling and subcellular defects by prazosin in heart failure due to myocardial infarction","volume":"5","author":"Babick","year":"2012","journal-title":"J. Clin. Exp. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/jcp.24373","article-title":"Reversal of cardiac dysfunction and subcellular alterations by metoprolol in heart failure due to myocardial infarction","volume":"228","author":"Babick","year":"2013","journal-title":"J. Cell Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.HYP.34.6.1197","article-title":"Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene expression after aortic banding","volume":"34","author":"Massart","year":"1999","journal-title":"Hypertension"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/00004872-199306003-00009","article-title":"Beta-blocking agents with vasodilator activity","volume":"11","author":"Rosendorff","year":"1993","journal-title":"J. Hypertens. Suppl."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/clc.4960140608","article-title":"Prazosin in chronic congestive heart failure due to ischemic heart disease","volume":"14","author":"Antani","year":"1991","journal-title":"Clin. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0002-9149(80)90656-6","article-title":"Long-term therapy of heart failure with prazosin: A randomized double blind trial","volume":"45","author":"Colucci","year":"1980","journal-title":"Am. J. Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0002-9343(80)90158-8","article-title":"Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure","volume":"68","author":"Goldman","year":"1980","journal-title":"Am. J. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurjhf\/hfq135","article-title":"\u03b1-receptor blockade improves muscle perfusion and glucose uptake in heart failure","volume":"12","author":"Gomes","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0002-9149(97)89342-3","article-title":"Combined \u03b1-\u03b2 blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure","volume":"77","author":"Kukin","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): Randomised controlled trial","volume":"362","author":"Swedberg","year":"2003","journal-title":"Lancet"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"ALLHAT Collaborative Research Group (2000). Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA, 283, 1967\u20131975.","DOI":"10.1001\/jama.283.15.1967"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.amjcard.2009.03.030","article-title":"Impact of \u03b11-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure","volume":"104","author":"Dhaliwal","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yjmcc.2016.09.006","article-title":"Sarcolemmal \u03b12-adrenoceptors control protective cardiomyocyte-delimited sympathoadrenal response","volume":"100","author":"Kokoz","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pharmthera.2019.01.007","article-title":"Sarcolemmal \u03b12-adrenoceptors in feedback control of myocardial response to sympathetic challenge","volume":"197","author":"Alekseev","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yjmcc.2013.12.030","article-title":"Alpha-2 adrenoceptors and imidazoline receptors in cardiomyocytes mediate counterbalancing effect of agmatine on NO synthesis and intracellular calcium handling","volume":"68","author":"Maltsev","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1006\/jmcc.1997.0522","article-title":"Phosphatidic acid: A potential signal transducer for cardiac hypertrophy","volume":"29","author":"Dhalla","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1139\/y06-098","article-title":"Phospholipid-mediated signaling systems as novel targets for treatment of heart disease","volume":"85","author":"Tappia","year":"2007","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1139\/Y10-019","article-title":"Phospholipase C as a potential target for cardioprotection during oxidative stress","volume":"88","author":"Tappia","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.freeradbiomed.2006.03.025","article-title":"Oxidative stress and redox regulation of phospholipase D in myocardial disease","volume":"41","author":"Tappia","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_105","first-page":"431","article-title":"Mechanisms for the defects in phospholipid signal transduction in diabetic cardiomyopathy","volume":"51","author":"Tappia","year":"2014","journal-title":"Indian J. Biochem. Biophys."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-4020-8831-5_11","article-title":"Phospholipid-mediated signaling and heart disease","volume":"49","author":"Tappia","year":"2008","journal-title":"Subcell. Biochem."},{"key":"ref_107","first-page":"149","article-title":"Involvement of phospholipase C in the norepinephrine\u2014Induced hypertrophic response in cardiomyocytes","volume":"53","author":"Tappia","year":"2022","journal-title":"Scr. Med."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Tappia, P.S., Ramjiawan, B., and Dhalla, N.S. (Can. J. Physiol. Pharmacol., 2022). Role of phospholipase C in catecholamine-induced increase in myocardial protein synthesis, Can. J. Physiol. Pharmacol., in press.","DOI":"10.1139\/cjpp-2022-0189"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/16\/2488\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:07:05Z","timestamp":1760141225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/16\/2488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":108,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["cells11162488"],"URL":"https:\/\/doi.org\/10.3390\/cells11162488","relation":{},"ISSN":["2073-4409"],"issn-type":[{"type":"electronic","value":"2073-4409"}],"subject":[],"published":{"date-parts":[[2022,8,11]]}}}